Clinical Trial Update: Effect of Complementary Intracoronary Streptokinase Administration Immediately After Primary Percutaneous Coronary Intervention on Microvascular Perfusion and Late Term Infarct Size in Patients With Acute Myocardial Infarction [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating whether giving streptokinase intracoronarily after primary PCI improves microvascular perfusion and reduces late infarct size in acute …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Streptokinase (streptokinase)

Snippet

Sponsor: Istanbul University | Conditions: Acute Myocardial Infarction | Phase 4 | Status: COMPLETED